DNA immunization with a combination of rat neu antigen, CD86, and 4-1BB ligand results in the generation of HER-2/neu (HER-2) antibodies in neu transgenic mice

被引：0
|
作者：
Buonavista, N
Shiota, FM
Hellström, KE
Hellström, I
Disis, ML
机构：
[1] Univ Washington, Pacific NW Res Inst, Seattle, WA 98195 USA
[2] Univ Washington, Div Oncol, Seattle, WA 98195 USA
来源：
CANCER GENE THERAPY | 1998年 / 5卷 / 06期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
O5
引用
收藏
页码：S2 / S2
页数：1
相关论文
共 50 条
  • [1] HER-2/neu is a tumor rejection target in tolerized HER-2/neu transgenic mice
    Reilly, RT
    Gottlieb, MBC
    Ercolini, AM
    Machiels, JPH
    Kane, CE
    Okoye, FI
    Muller, WJ
    Dixon, KH
    Jaffee, EM
    [J]. CANCER RESEARCH, 2000, 60 (13) : 3569 - 3576
  • [2] Activity of DNA vaccines encoding self or heterologous Her-2/neu in Her-2 or neu transgenic mice
    Jacob, Jennifer
    Radkevich, Olga
    Forni, Guido
    Zielinski, John
    Shim, David
    Jones, Richard F.
    Wei, Wei-Zen
    [J]. CELLULAR IMMUNOLOGY, 2006, 240 (02) : 96 - 106
  • [3] Analysis of HER-2/neu Receptor Expression and the Level of Neuronal Apoptosis in HER-2/neu Transgenic Mice during Aging
    Solovyova, A. S.
    Sokolova, Yu O.
    Anisimov, V. N.
    Bazhanova, E. D.
    [J]. BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2019, 167 (04) : 512 - 515
  • [4] Analysis of HER-2/neu Receptor Expression and the Level of Neuronal Apoptosis in HER-2/neu Transgenic Mice during Aging
    A. S. Solovyova
    Yu. O. Sokolova
    V. N. Anisimov
    E. D. Bazhanova
    [J]. Bulletin of Experimental Biology and Medicine, 2019, 167 : 512 - 515
  • [5] Booster immunizations with DNA plasmids encoding HER-2/neu prevent spontaneous mammary cancer in HER-2/neu transgenic mice over life span
    Provinciali, Mauro
    Barucca, Alessandra
    Orlando, Fiorenza
    Pierpaoli, Elisa
    [J]. SCIENTIFIC REPORTS, 2017, 7
  • [6] Booster immunizations with DNA plasmids encoding HER-2/neu prevent spontaneous mammary cancer in HER-2/neu transgenic mice over life span
    Mauro Provinciali
    Alessandra Barucca
    Fiorenza Orlando
    Elisa Pierpaoli
    [J]. Scientific Reports, 7
  • [7] Immunization with a HER-2/neu helper peptide generates HER-2/neu CD8 T-cell immunity in cancer patients
    Knutson, KL
    Schiffman, K
    Disis, ML
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2001, 107 (04): : 477 - 484
  • [8] Generation of T-cell immunity to the HER-2/neu protein after active immunization with HER-2/neu peptide-based vaccines
    Disis, ML
    Gooley, TA
    Rinn, K
    Davis, D
    Piepkorn, M
    Cheever, MA
    Knutson, KL
    Schiffman, K
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (11) : 2624 - 2632
  • [9] Prevention of spontaneous mammary adenocarcinoma in HER-2/neu transgenic mice by foreign DNA
    Sfondrini, L
    Besusso, D
    Rumio, C
    Rodolfo, M
    Ménard, S
    Balsari, A
    [J]. FASEB JOURNAL, 2002, 16 (13): : 1749 - 1754
  • [10] Phase 1 study of infusion of HER-2/neu specific T cells in patients with advanced stage HER-2/neu overexpressing cancers who have received a HER-2/neu vaccine
    Dang, Yushe
    Salazar, Lupe G.
    Coveler, Andrew
    Waisman, James
    Higgins, Doreen
    Childs, Jennifer
    Bates, Nicole
    Slota, Meredith
    Disis, Mary L.
    [J]. JOURNAL OF IMMUNOLOGY, 2009, 182
12345